Bioventus (BVS)
(Delayed Data from NSDQ)
$6.30 USD
+0.14 (2.27%)
Updated May 22, 2024 04:00 PM ET
After-Market: $6.29 -0.01 (-0.16%) 7:58 PM ET
1-Strong Buy of 5 1
C Value D Growth C Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $0.07 | 0.00% |
Earnings Summary
For their last quarter, Bioventus (BVS) reported earnings of $0.07 per share, beating the Zacks Consensus Estimate of $-0.05 per share. This reflects a positive earnings surprise of 240.00%. Look out for BVS's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of $0.07 per share, reflecting a year-over-year decrease of 50%.
Earnings History
Price & Consensus
Zacks News for BVS
PTC Therapeutics (PTCT) Reports Q4 Loss, Lags Revenue Estimates
BVS: What are Zacks experts saying now?
Zacks Private Portfolio Services